Amy Roberts, LPE | |
1309 N Church St, Atkins, AR 72823-3230 | |
(479) 641-0730 | |
(479) 641-0732 |
Full Name | Amy Roberts |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 1309 N Church St, Atkins, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780020479 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 12-03E (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amy Roberts, LPE 1309 N Church St, Atkins, AR 72823-3230 Ph: (479) 641-0730 | Amy Roberts, LPE 1309 N Church St, Atkins, AR 72823-3230 Ph: (479) 641-0730 |
News Archive
Nearly half of parents of children under age 18 say their stress levels related to the coronavirus pandemic are high, with managing their kids' online learning a significant source of stress for many, according to a new survey by the American Psychological Association.
"The Department of Defense is estimated to have spent more than half a billion dollars to support a variety of global health-related activities in fiscal year 2012 - more than either the Centers for Disease Control and Prevention or the National Institutes of Health dedicated to global health in the same year, according to a new report from the Kaiser Family Foundation," a report summary on the foundation's webpage states.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection, nearly 70 percent of surveyed infectious disease specialists and internists will use Optimer's fidaxomicin and nearly half will use Medarex/Merck's CDA1 and CDB1, one year after the launch of these agents. The lower recurrent/relapse rate associated with fidaxomicin and CDA1/CDB1 is the most influential attribute surveyed clinicians cite in their decisions to prescribe these emerging agents for CDI.
UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia.
Trade between countries usually involves products. However, one successful export from the United States to the Netherlands, Norway and several other countries is a cognitive therapy treatment program created by University of Iowa experts to help people with borderline personality disorder.
› Verified 2 days ago